Serveur d'exploration SRAS - Exploration (Accueil)

Index « Titre (en) » - entrée « highly »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
highlights < highly < higieny  Facettes :

List of bibliographic references indexed by highly

Number of relevant bibliographic references: 65.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000030 (2020) Yeyan He [République populaire de Chine] ; Chanying Zheng [République populaire de Chine][Replication and transmission mechanisms of highly pathogenic human coronaviruses].
000048 (2020) M. Liu [République populaire de Chine] ; R E Feng [République populaire de Chine] ; Q. Li [République populaire de Chine] ; H K Zhang [République populaire de Chine] ; Y G Wang [République populaire de Chine][Comparison of pathological changes and pathogenic mechanisms caused by H1N1 influenza virus, highly pathogenic H5N1 avian influenza virus, SARS-CoV, MERS-CoV and 2019-nCoV coronavirus].
000165 (2020) Shibo Jiang [République populaire de Chine, États-Unis] ; Zheng-Li Shi [République populaire de Chine]The First Disease X is Caused by a Highly Transmissible Acute Respiratory Syndrome Coronavirus
000403 (2020) Francesco Di Pierro [Oman] ; Alexander Bertuccioli [Italie] ; Ilaria Cavecchia [Italie]Possible therapeutic role of a highly standardized mixture of active compounds derived from cultured Lentinula edodes mycelia (AHCC) in patients infected with 2019 novel coronavirus.
000419 (2020) Jos H. Verbeek [Pays-Bas] ; Blair Rajamaki [Finlande] ; Sharea Ijaz ; Riitta Sauni [Finlande] ; Elaine Toomey [Irlande (pays)] ; Bronagh Blackwood ; Christina Tikka ; Jani H. Ruotsalainen ; F Selcen Kilinc BalciPersonal protective equipment for preventing highly infectious diseases due to exposure to contaminated body fluids in healthcare staff.
000541 (2020) Shuai Xia [République populaire de Chine] ; Meiqin Liu [République populaire de Chine] ; Chao Wang [République populaire de Chine] ; Wei Xu [République populaire de Chine] ; Qiaoshuai Lan [République populaire de Chine] ; Siliang Feng [République populaire de Chine] ; Feifei Qi [République populaire de Chine] ; Linlin Bao [République populaire de Chine] ; Lanying Du [États-Unis] ; Shuwen Liu [République populaire de Chine] ; Chuan Qin [République populaire de Chine] ; Fei Sun [République populaire de Chine] ; Zhengli Shi [République populaire de Chine] ; Yun Zhu [République populaire de Chine] ; Shibo Jiang [République populaire de Chine, États-Unis] ; Lu Lu [République populaire de Chine]Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion
000606 (2020) Gerald J. Kost [États-Unis]Geospatial Hotspots Need Point-of-Care Strategies to Stop Highly Infectious Outbreaks: Ebola and Coronavirus.
000711 (2020) Guangyu Qiu [Suisse] ; Zhibo Gai [Suisse, République populaire de Chine] ; Yile Tao [Suisse] ; Jean Schmitt [Suisse] ; Gerd A. Kullak-Ublick [Suisse] ; Jing Wang [Suisse]Dual-Functional Plasmonic Photothermal Biosensors for Highly Accurate Severe Acute Respiratory Syndrome Coronavirus 2 Detection
000A34 (2020) Meng Yuan [États-Unis] ; Nicholas C. Wu [États-Unis] ; Xueyong Zhu [États-Unis] ; Chang-Chun D. Lee [États-Unis] ; Ray T. Y. So [République populaire de Chine] ; Huibin Lv [République populaire de Chine] ; Chris K. P. Mok [République populaire de Chine] ; Ian A. Wilson [États-Unis]A highly conserved cryptic epitope in the receptor-binding domains of SARS-CoV-2 and SARS-CoV
000B03 (2019) Jean K. Millet ; Tiffany Tang [États-Unis] ; Lakshmi Nathan [États-Unis] ; Javier A. Jaimes [États-Unis] ; Hung-Lun Hsu ; Susan Daniel [États-Unis] ; Gary R. Whittaker [États-Unis]Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting.
000B04 (2019) Jos H. Verbeek ; Blair Rajamaki ; Sharea Ijaz ; Christina Tikka ; Jani H. Ruotsalainen ; Michael B. Edmond ; Riitta Sauni ; F Selcen Kilinc BalciPersonal protective equipment for preventing highly infectious diseases due to exposure to contaminated body fluids in healthcare staff.
000B75 (2019) Ariane J. Brown [États-Unis] ; John J. Won [États-Unis] ; Rachel L. Graham [États-Unis] ; Kenneth H. Dinnon [États-Unis] ; Amy C. Sims [États-Unis] ; Joy Y. Feng [États-Unis] ; Tomas Cihlar [États-Unis] ; Mark R. Denison [États-Unis] ; Ralph S. Baric [États-Unis] ; Timothy P. Sheahan [États-Unis]Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase
000C09 (2018) Stacy R. Webb [États-Unis] ; Stacy E. Smith [États-Unis] ; Michael G. Fried [États-Unis] ; Rebecca Ellis Dutch [États-Unis]Transmembrane Domains of Highly Pathogenic Viral Fusion Proteins Exhibit Trimeric Association In Vitro.
000D63 (2017) Sumei Li [République populaire de Chine] ; Xiuhua Jia [République populaire de Chine] ; Xintian Shen [République populaire de Chine] ; Zhuwen Wei [République populaire de Chine] ; Zhiyan Jiang [République populaire de Chine] ; Yixian Liao [République populaire de Chine] ; Yiming Guo [République populaire de Chine] ; Xiaojun Zheng [République populaire de Chine] ; Guohua Zhong [République populaire de Chine] ; Gaopeng Song [République populaire de Chine]Structure-activity relationships of 3-O-β-chacotriosyl oleanic acid derivatives as entry inhibitors for highly pathogenic H5N1 influenza virus.
000F63 (2016) Jos H. Verbeek ; Sharea Ijaz ; Christina Mischke ; Jani H. Ruotsalainen ; Erja M Kel ; Kaisa Neuvonen ; Michael B. Edmond ; Riitta Sauni ; F Selcen Kilinc Balci ; Raluca C. MihalachePersonal protective equipment for preventing highly infectious diseases due to exposure to contaminated body fluids in healthcare staff.
001032 (2016) David J. Weber [États-Unis] ; William A. Rutala [États-Unis] ; William A. Fischer [États-Unis] ; Hajime Kanamori [États-Unis] ; Emily E. Sickbert-Bennett [États-Unis]Emerging infectious diseases: Focus on infection control issues for novel coronaviruses (Severe Acute Respiratory Syndrome-CoV and Middle East Respiratory Syndrome-CoV), hemorrhagic fever viruses (Lassa and Ebola), and highly pathogenic avian influenza viruses, A(H5N1) and A(H7N9)
001200 (2015) Aleksandra A. Zasada[Selection of disposable personal protective equipment for work with samples containing highly pathogenic microorganisms].
001203 (2015) L. Ehlkes [Allemagne] ; B. Kreuels ; N G Schwarz ; Jürgen May[Epidemiology of Ebola virus disease and of other highly contagious, life-threatening diseases with low incidence in Germany].
001216 (2015) Renxi Wang [République populaire de Chine] ; He Xiao [République populaire de Chine] ; Renfeng Guo [États-Unis, Allemagne] ; Yan Li [République populaire de Chine] ; Beifen Shen [République populaire de Chine]The role of C5a in acute lung injury induced by highly pathogenic viral infections
001293 (2015) Jean Kaoru Millet [États-Unis] ; Béatrice NalInvestigation of the functional roles of host cell proteins involved in coronavirus infection using highly specific and scalable RNA interference (RNAi) approach.
001313 (2015) Frederick M. Burkle [États-Unis]Global Health Security Demands a Strong International Health Regulations Treaty and Leadership From a Highly Resourced World Health Organization.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "highly" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "highly" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    highly
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021